Non-invasive imaging of sentinel lymph node with a Multispectral Optoacoustic Tomography (MSOT-Scanner) in patients with malignant melanoma

Non-invasive imaging of sentinel lymph node with a Multispectral Optoacoustic Tomography (MSOT-Scanner) in patients with malignant melanoma - MSOT_SLN

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00006329

Enrollment

Registered

2014-07-14

Start date

2014-08-18

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C43

Interventions

Group 1: Preoperative sentinel lymph node (SLN) in vivo detection with Indocyanin green (ICG) and handheld MSOT-Imaging (Multispectral Optoacoustic Tomography) and postoperative ex vivo MSOT examinati

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with a malignant melanoma - stages Ib and II (AJCC 2009)

Exclusion criteria

Exclusion criteria: age < 18 years, known intolerance to ICG, iodine allergy

Design outcomes

Primary

Measure	Time frame
Detectionrate of the fluorescent SLN (ICG) prior to surgery by multispectral optoacoustic tomography	—

Secondary

Measure	Time frame
Detectionrate of the SLN melanin signal prior to surgery by multispectral optoacoustic tomography	—

Countries

Germany

Contacts

Public ContactIngo Stoffels

Klinik für Dermatologie, Venerologie und AllergologieUniversitätsklinikum Essen

ingo.stoffels@uk-essen.de0201-723-4756

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026